Issue link: http://osercommunicationsgroup.uberflip.com/i/858127
Chain Drugstore Daily 5 1 Sunday, August 20, 2017 KM: Checkpoint is experienced in run- ning large-scale programs for numerous manufacturers and retailers, managing every aspect of source tagging from package design (materials, adhesives, offset printing) to manufacturing (auto- application, high-speed tagging) to in- store compliance. Checkpoint Systems is a global leader in merchandise availability solu- tions for the retail industry, encompass- ing loss prevention and merchandise vis- ibility. A division of CCL Industries, Checkpoint provides source to store solu- tions, enabling retailers to achieve accu- rate real-time inventory, accelerate the replenishment cycles, prevent out-of- stocks and reduce theft, thus improving merchandise availability and the shop- per's experience. Checkpoint's customer benefits from increased sales and profits by implementing merchandise availabili- ty solutions to ensure the right mer- chandise is available at the right place and time when consumers are ready to buy. CDD: How can drugstore chains address SKUs prone to shoplifting and ensure that their stores are consistently applying the wide range of tags in store? Checkpoint Systems (Cont'd. from p. 1) KM: Visible EAS source tagging is the first line of defense in deterring shoplifting. Some stores reinforce hands-on training by placing compli- ance posters in the back room to show associates the proper placement and application of specific EAS tags designed for different items. In addi- tion, to ensure that only tag-protected high-risk products are restocked, many are using color-coded or other visual cues on the shelves themselves to alert employees that only protected products should be stocked. Finally, focusing your efforts on the most high-risk SKUs provides the most benefit, since for many retailers, 10 percent of prod- ucts comprise 90 percent of shrink risk. CDD: How can customers get more information? KM: For additional information on how your stores can consistently pro- tect high risk products with visible tags to deter ORC incidents, please reach out to our Checkpoint Source Tagging Team. Visit Checkpoint Systems at booth #3918. For more information, email sourcetagctr@checkpt.com or call 800.257.5540 ext. 4200. and customer needs. Starting with a sin- gle warehouse facility in Central Illinois, the company has grown into a national healthcare provider through a culture of collaboration and focus on providing an extraordinary customer experience. The company's historical strength of providing industry trading partners national reach through a full-service wholesaler, while retaining the flexibility to launch pilot programs and other cus- tom solutions, created a strong founda- tion that aligns well with today's special- ty solutions environment. With the rapid growth in specialty products in the mid-1990s, H. D. Smith launched specialty distributor Smith Medical Partners to support institutional customers and emerging independent specialty pharmacies, with improved access to drugs in limited distribution networks. With a focus on niche special- ty markets, Smith Medical Partners has expanded its footprint in key clinics, institutions and other sites of care by providing a flexible option to manufac- turers and exceptional service to its cus- tomers. In 2011, Smith Medical Partners H. D. Smith (Cont'd. from p. 1) began offering third party logistics (3PL) services with a vision of being a true strategic supply chain partner that could support both emerging and large pharma clients. Smith Medical Partners' 3PL business has grown rapidly, and provides a full suite of flexible solutions, includ- ing: storage; security and logistics for ambient, cold chain and controlled prod- ucts; order-to-cash; sampling programs; and real-time reporting and outstanding customer service. Smith Medical Partners now pro- vides a complete set of solutions to sup- port the product journey from pre-com- mercialization (clinical trial support) to delivery to patients through pharmacies, clinics and direct-to-patient, home deliv- ery programs. With its recent expansion to a new 340,000 square foot facility in Carol Stream, Illinois, Smith Medical Partners, part of the collective H. D. Smith compa- nies, is well positioned to support the increased demand for tailored distribu- tion solutions, and has created an econo- my of scale that provides cost savings to manufacturers and pharmacies. Visit H. D. Smith at booth #3723. For more information, go to www.hdsmith companies.com. distributors, health systems and govern- ment agencies. Although the company historically has focused on providing top-quality generic medications, it is now interested in making branded medicines more affordable as well. Responsible Partner The relationships West-Ward Pharmaceuticals Corp. has with its cus- tomers are extremely important to the company. It is sharply focused on antici- pating, meeting and exceeding their needs and expectations. Accordingly, it is dedicated to using all of its resources and world-class manufacturing facilities to deliver on its promises. Reliable Supplier West-Ward Pharmaceuticals Corp. believes it is its corporate responsibility to reliably supply pharmaceuticals to the market. As the U.S. agent and subsidiary of Hikma Pharmaceuticals PLC, it has access to resources around the world to enable it to achieve its goal, which is to supply a diverse portfolio of high-quali- ty, yet affordable pharmaceutical prod- ucts. Quality Commitment West-Ward Pharmaceuticals Corp. is committed to reliably supplying quality products to meet today's diverse health- care needs. Its goal is to continuously improve manufacturing operations and surpass industry quality standards. West-Ward Pharmaceuticals (Cont'd. from p. 1) Diverse Portfolio West-Ward Pharmaceuticals Corp. deliv- ers affordable oral and injectable phar- maceuticals across a wide array of thera- peutic areas. It understands and assumes the risks presented by today's market dynamics to provide a steady supply of product to the industry. It is committed to expanding its portfolio of products and services to customers through acquisition and process innovation. Customer First The company's commitment to provide a reliable supply of quality pharmaceuti- cals starts with a customer-first approach. It will forego efficiencies by holding excess inventory to protect our customers from market shortages. It offers personal- ized services and dynamic communica- tions to exceed customer expectations. Solid Foundation West-Ward Pharmaceuticals Corp. is a wholly-owned U.S. agent and subsidiary of Hikma Pharmaceutical PLC. Hikma is a rapidly growing multinational pharma- ceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products. In 2016, Hikma achieved revenue of $1,950 million and profit attributable to share- holders of $155 million. For more information, visit booth #601, go to www.west-ward.com or call 732.542.1191. ADVANTAGE DELIVERS FEEDBACK TO IMPROVE VENDOR PARTNER INTERACTION Advantage Group International is a third-party, unbiased, jointly-spon- sored, annual benchmarking program that targets the functions that matter most to improving business relation- ships between retailers and suppliers by helping each side see how they are perceived and how disconnects can be identified and corrected. Located in Chicago, Illinois, the company has been helping suppliers and retailers since 1988. The Advantage Report measures more than 20 practices that are relevant to strengthening all business practices. The company delivers a business tool to be used to evaluate performance rel- ative to competition and peers. The process is key to identifying strengths, weaknesses and opportunities to improve. Advantage's proven method- ology and processes delivers to more than 200 leading retailers worldwide, in more than 40 countries. Advantage Group International provides reality checks and feedback opportunities for both suppliers and retailers. For more than 500 retailers and suppliers around the world, the company helps clients improve busi- ness results with key trading partners. The data collected provides Board level metrics at some of the largest CPG companies in the world. Strong performance in the Advantage study has been proven to correlate with strong financial performance for both retailers and suppliers in large drug chain stores, and their OTC and general mer- chandise suppliers. Advantage's 2016 study has shown that many companies experience a "reality check" regarding their retailers' ability to interact with suppliers and vice versa, but more importantly, the study shows companies how to restructure and improve that interaction so it is more effective for all concerned. Patty Basche, Director, U.S. Client Services, noted, "You can't manage what you don't measure. Without benchmarking you don't have context on your performance. We measure the other half of the trading relationship – the 'how you do what you do' – across sales, marketing and supply chain. We share best-in-class advice from retail- ers and suppliers so their trading part- ners can raise their game and financial performance. We have thousands of industry professionals in the U.S. par- ticipating every year and 36,000- plus worldwide. Everything we do remains confiden- tial so individuals can provide 'the unvarnished truth' in their feedback without fear of reprisal. This breadth and depth gives our clients unparal- leled insights into strengths, opportu- nities and improvement options. Our people are available to coach and guide customers through a wealth of insights so that they will be able to more effec- tively address specific business needs. We're not dumping data, we're collab- orating with our clients, so they, in turn, can collaborate and drive better business results with their customers." For more information, visit www .advantagegroup.com or contact Patty Basche, Director, U.S. Client Services by calling 224.730.4198 or emailing pbasche@advantagegroup.com.